Home > Subjects matches any of "Other novel substances"

Displaying results 1 to 40 of 253.
Refine search | New search | 1 | 2 | 3 | 4 | 5 | 6 | 7 | Next
Order the results:
Export 253 results as
1.
[FactSheet] HRB National Drugs Library. (2025) Factsheet: Opioids - the Irish situation. Dublin: HRB National Drugs Library.
2.
[FactSheet] HRB National Drugs Library. (2025) Factsheet: Sedatives and tranquilisers - the Irish situation. Dublin: HRB National Drugs Library.
3.
[FactSheet] Simon Community Scotland, Public Health Scotland. (2025) How to save a life: emergency response to a drug overdose, and harm reduction advice. Edinburgh: Public Health Scotland.
4.
[Report] Muttucomaroe, Lauren and Millar, Seán and Hanrahan, Michael T and Mongan, Deirdre and Joyce, Mary and Corcoran, Paul and Byrne, Michael (2025) Problem drug use in Cork City: a study on prevalence and harms. Cork: University College Cork.
5.
[Report] Northern Ireland Statistics and Research Agency. (2025) Drug-related and drug misuse deaths in Northern Ireland, 2023. Belfast: Northern Ireland Statistics and Research Agency.
6.
[Article] Millar, Seán (2025) Prescription drug prescribing trends in Irish prisons, 2012–2020. Drugnet Ireland, Issue 90, Winter 2025. pp. 32-33.
7.
[Report] Health Research Board. Irish National Focal Point to the European Drugs Agency. (2025) Ireland: national report for 2024 - drug markets and crime. Dublin: Health Research Board.
8.
[Report] MEDICRIME Unit, Directorate General: Human Rights and Rule of Law. (2025) An assessment of publicly reported incidents of illicit diversion and falsification of medicines. Strasbourg: European Commission.
10.
[Article] Connolly, Dean J and Coduri-Fulford, Santino and Macdonald, Katherine and Gilchrist, Gail and Muschialli, Luke (2025) Consent and violence amongst men in the context of sexualised drug use: a systematic scoping review. International Journal of Drug Policy, 136. https://doi.org/10.1016/j.drugpo.2025.104706
12.
[Article] Wolfe, Caitlin E and Rowe, Ashley and Hudson, Simon and Archer, John Rh and Dargan, Paul I and Wood, David M (2025) Reported recreational drug and new psychoactive substance use versus laboratory detection of substances by high-resolution mass spectrometry in patients presenting to an emergency department in London with acute drug toxicity. Clinical Toxicology, 62, (11), pp. 693-697. https://doi.org/10.1080/15563650.2024.2402070
13.
[Article] McNeilage, Amy G and Sim, Alison and Nielsen, Suzanne and Murnion, Bridin and Ashton-James, Claire E (2024) Experiences of misuse and symptoms of dependence among people who use gabapentinoids: a qualitative systematic review. International Journal of Drug Policy, 133. https://doi.org/10.1016/j.drugpo.2024.104605
14.
[Dataset] Primary Care Reimbursement Service. (2024) GMS benzodiazepine and Z drug claims [Ireland].
15.
[News] [thejournal.ie] , Flynn, Valerie Medical Council suggests controls needed on widely used prescription drug. (13 Oct 2024)
16.
[Report] WEDINOS. (2024) PHILTRE August 2024. Cardiff: WEDINOS.
17.
[Webpage] WHO Expert Committee on Drug Dependence. (2024) Expert Committee on Drug Dependence information repository. URL: https://ecddrepository.org/en
19.
[Report] Harris, Julie and Gray, Ann Marie and Niblock, Tobias (2024) Increased complexity of clients’ substance use needs and service provider responses during and after the COVID-19 pandemic. Belfast: Northern Ireland Alcohol and Drugs Alliance.
20.
[Report] Walton, Sara E and Tracy, Erin and Shinefeld, Jennifer and Teixeira da Silva, Daniel and Denn, Max T and Quinter, Alexis D and DeBord, Joshua and Logan, Barry K and Krotulski, Alex J (2024) BTMPS — NPS Discovery new drug monograph. United States: Center for Forensic Science Research and Education.
22.
[Report] National Records of Scotland. (2024) Drug-related deaths in Scotland in 2023. Edinburgh: National Records of Scotland.
23.
[Report] Walton, Sara E and Teem, Denice and Krotulski, Alex J and Papsun, Donna M and Logan, Barry K (2024) Bromantane — NPS Discovery new drug monograph. United States: Center for Forensic Science Research and Education.
24.
[Article] Jiang, Xinyi and Connolly, Sarah and Strahan, Andrea E and Rivera Blanco, Liz and Mikosz, Christina A and Guy, Gery P and Dowell, Deborah (2024) Reported xylazine use among adults aged ≥18 years evaluated for substance use treatment - United States, July 2022-September 2023. MMWR. Morbidity and Mortality Weekly Report, 73, (26), pp. 594-599. /10.15585/mmwr.mm7326a2
25.
[Report] UNODC Laboratory and Scientific Service. (2024) Current NPS threats volume VII. Vienna: United Nations Office on Drugs and Crime.
28.
[Report] United Nations Office on Drugs and Crime. (2024) The challenge of new psychoactive substances - a technical update. Vienna: United Nations.
29.
[Audio] Society for the Study of Addiction. Calder, Robert (2024) Addiction audio. Season 2, 2024. London: Society for the Study of Addiction.
31.
[Article] Glancy, Megan and Palmateer, Norah and Yeung, Alan and Hickman, Matthew and Macleod, John and Bishop, Jen and Barnsdale, Lee and Trayner, Kirsten M A and Priyadarshi, Saket and Wallace, Jason and Hutchinson, Sharon and McAuley, Andrew (2024) Risk of drug-related death associated with co-prescribing of gabapentinoids and z-drugs among people receiving opioid-agonist treatment: a national retrospective cohort study. Psychiatry Research, https://doi.org/10.1016/j.psychres.2024.116028
32.
[Report] United Kingdom. Office for National Statistics. (2024) Drug related deaths where gabapentin or pregabalin were mentioned, England and Wales: 2018 to 2022. London: Office for National Statistics.
33.
[Report] Chrzanowska, Agata and Man, Nicola and Sutherland, Rachel and Degenhardt, Louisa and Peacock, Amy (2024) Trends in overdose and other drug-induced deaths in Australia, 2003 - 2023. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney.
35.
[Report] Public Health Scotland. (2024) Scotland. Public health alert: Xylazine – newly detected drug. Edinburgh: Public Health Scotland.
36.
[Article] Edinoff, Amber N and Sall, Saveen and Upshaw, William C and Spillers, Noah J and Vincik, LeighAnn Y and De Witt, Adalyn S and Murnane, Kevin S and Kaye, Adam M and Kaye, Alan D (2024) Xylazine: a drug adulterant of clinical concern. Current Pain and Headache Reports, 28. pp. 417-426. https://doi.org/10.1007/s11916-024-01211-z
37.
[News] [RTE radio] , Byrne, Claire ‘Zombie’ drug xylazine found in UK vapes – could it be here? (10 Apr 2024)
38.
[Article] Weber, Andrea Nicole and Trebach, Joshua and Brenner, Marielle A and Thomas, Mary Margaret and Bormann, Nicholas L (2024) Managing opioid withdrawal symptoms during the fentanyl crisis: a review. Substance Abuse and Rehabilitation, 15. pp. 59-71. https://doi.org/10.2147/SAR.S433358
39.
[Report] Canadian Centre on Substance Use and Addiction. (2024) Drug Checking Symposium October 5–7, 2023: summary report. Ottawa: Canadian Centre on Substance Use and Addiction.
40.
[Report] National Patient Safety Office. (2024) National Healthcare Quality Reporting System: report 2023. Dublin: Department of Health.